Additionally, CD107a degranulation and cytotoxicity assays demonstrated that hGM3/CD28H CAR-T cells exerted superior tumor cell killing relative to CD8H and IgGH variants (Figures 2K–M). The gene discussed is TMIGD2; the disease is neoplasm.